Cargando…

Immune Persistence against SARS-CoV-2 after Primary and Booster Immunization in Humans: A Large-Scale Prospective Cohort Study

Amid the ongoing global COVID-19 pandemic, limited literature exists on immune persistence after primary immunization and the immunogenic features of booster vaccines administered at different time intervals. Therefore, this study aimed to determine the immune attenuation of neutralizing antibodies...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Juan, Xie, Hui, Chen, Weixin, Chen, Meng, Bai, Shuang, Zhao, Wei, Zhou, Tao, Gao, Pei, Zhang, Lichi, Wang, Quanyi, Pang, Xinghuo, Huang, Chun, Wu, Jiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609025/ https://www.ncbi.nlm.nih.gov/pubmed/36298542 http://dx.doi.org/10.3390/vaccines10101677

Ejemplares similares

Evaluation of Immunogenicity by Pseudovirus Neutralization Assays for SARS‐CoV‐2 Variants after Primary and Booster Immunization
por: Xie, Hui, et al.
Publicado: (2022)

The kinetics of IgG subclasses and contributions to neutralizing activity against SARS‐CoV‐2 wild‐type strain and variants in healthy adults immunized with inactivated vaccine
por: Chen, Weixin, et al.
Publicado: (2022)

Status of Humoral and Cellular Immune Responses within 12 Months following CoronaVac Vaccination against COVID-19
por: Zhao, Wei, et al.
Publicado: (2022)

Factors Influencing Persistence of Diphtheria Immunity and Immune Response to a Booster Dose in Healthy Slovak Adults
por: Petráš, Marek, et al.
Publicado: (2019)

Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study
por: Jara, Alejandro, et al.
Publicado: (2022)

Evaluation of the immunization effectiveness of bOPV booster immunization and IPV revaccination
por: Yu-ping, Zhao, et al.
Publicado: (2023)

Waning immunity to SARS-CoV-2: implications for vaccine booster strategies
por: Altmann, Daniel M, et al.
Publicado: (2021)

Differentially induced immunity in buccal and nasal mucosae after vaccination for SARS–CoV–2: Prospects for mass scale immunity-screening in large populations
por: Tsamadou, Chrysanthi, et al.
Publicado: (2022)

Immune Cell Landscaping Reveals Distinct Immune Signatures of Inflammatory Bowel Disease
por: Bai, Xiaowu, et al.
Publicado: (2022)

Infectious Disease Surveillance and Early Warning System During Beijing Olympic Games
por: Pang, Xinghuo, et al.
Publicado: (2017)

Characterization of Adaptive Immune Responses to SARS-CoV-2 Updated Bivalent Booster
por: Wachter, Brianna, et al.
Publicado: (2023)

Previous immunity shapes immune responses to SARS-CoV-2 booster vaccination and Omicron breakthrough infection risk
por: Pérez-Alós, Laura, et al.
Publicado: (2023)

Immune persistence and response to booster dose of Vi-DT vaccine at 27.5 months post-first dose
por: Capeding, Maria Rosario, et al.
Publicado: (2022)

Associated Factors and Immune Response to the Hepatitis B Vaccine with a Standard Schedule: A Prospective Study of People with HIV in China
por: Nie, Li, et al.
Publicado: (2023)

Covid-19 Vaccines — Immunity, Variants, Boosters
por: Barouch, Dan H.
Publicado: (2022)

Seroprevalence Study of Pertussis in Adults at Childbearing Age and Young Infants Reveals the Necessity of Booster Immunizations in Adults in China
por: Chen, Zhiyun, et al.
Publicado: (2022)

Booster Immunization Improves Memory B Cell Responses in Older Adults Unresponsive to Primary SARS-CoV-2 Immunization
por: Verheul, Marije K., et al.
Publicado: (2023)

Waning immunity to inactive SARS-CoV-2 vaccine in healthcare workers: booster required
por: Balkan, İlker İnanc, et al.
Publicado: (2022)

How to Naturally Support the Immune System in Inflammation—Essential Oils as Immune Boosters
por: Grazul, Magdalena, et al.
Publicado: (2023)

Inactivated SARS-CoV-2 booster vaccine enhanced immune responses in patients with chronic liver diseases
por: Liu, Yongmei, et al.
Publicado: (2023)

Immune persistence 17 to 20 years after primary vaccination with recombination hepatitis B vaccine (CHO) and the effect of booster dose vaccination
por: Zhao, Yu-Liang, et al.
Publicado: (2019)

Role of vitamins and minerals as immunity boosters in COVID-19
por: Kumar, Puneet, et al.
Publicado: (2021)

Extended SARS-CoV-2 RBD booster vaccination induces humoral and cellular immune tolerance in mice
por: Gao, Feng-Xia, et al.
Publicado: (2022)

Persistent Cellular Immunity to SARS-CoV-2 Infection
por: Breton, Gaëlle, et al.
Publicado: (2020)

Persistent cellular immunity to SARS-CoV-2 infection
por: Breton, Gaëlle, et al.
Publicado: (2021)

SARS‐CoV‐2 booster effect and waning immunity in hemodialysis patients: A cohort study
por: Goggins, Eibhlin, et al.
Publicado: (2023)

Partial recovery of SARS-CoV-2 immunity after booster vaccination in renal transplant recipients
por: Urra, J.M., et al.
Publicado: (2023)

Heterogeneity in Vaccinal Immunity to SARS-CoV-2 Can Be Addressed by a Personalized Booster Strategy
por: Stoddard, Madison, et al.
Publicado: (2023)

SARS-CoV-2 vaccination, booster, and infection in pregnant population enhances passive immunity in neonates
por: Murphy, Elisabeth A., et al.
Publicado: (2023)

Projecting the COVID-19 immune landscape in Japan in the presence of waning immunity and booster vaccination
por: Sasanami, Misaki, et al.
Publicado: (2023)

A homologous or variant booster vaccine after Ad26.COV2.S immunization enhances SARS-CoV-2–specific immune responses in rhesus macaques
por: He, Xuan, et al.
Publicado: (2022)

Exploring the path of persisting dysfunctional expectations—Development of the immunization scale IMS
por: Ewen, Anne-Catherine I., et al.
Publicado: (2022)

Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant
por: Zuo, Fanglei, et al.
Publicado: (2022)

Immunogenicity and Safety of a Booster Dose of Live Attenuated Varicella Vaccine, and Immune Persistence of a Primary Dose for Children Aged 2 to 6 Years
por: Zhang, Yukai, et al.
Publicado: (2022)

Humoral immunity and transcriptome differences of COVID-19 inactivated vacciane and protein subunit vaccine as third booster dose in human
por: Zhang, Yuwei, et al.
Publicado: (2022)

Intranasal booster using an Omicron vaccine confers broad mucosal and systemic immunity against SARS-CoV-2 variants
por: Wang, Qian, et al.
Publicado: (2023)

Fight COVID-19 depression with immunity booster: Curcumin for psychoneuroimmunomodulation
por: Soni, Vivek Kumar, et al.
Publicado: (2020)

Bioresponsive immune-booster-based prodrug nanogel for cancer immunotherapy
por: Ma, Xianbin, et al.
Publicado: (2022)

Pre-existing immunity modulates responses to mRNA boosters
por: Dangi, Tanushree, et al.
Publicado: (2022)

Importance of the COVID-19 Vaccine Booster Dose in Protection and Immunity
por: Abdollahi, Alireza, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u9u7oetlkae2q890ok91p85phb